Summary

vaccine, immunity, immunization, immunotherapy, dendritic cells, catalytic adjuvent, DC hyperactivation, antibody response, T-cell response, mRNA, adaptive immunity, LMP, infectious disease, oncology, inflammasome, IL-1 data, cGAS, antigen, CD-8 positive T-cells, immunogenicity, cancer

Description

We are an immunotherapy company unlocking lifelong protection from cancer and infectious diseases. Our novel dendritic cell stimuli platforms teach the immune system to engineer its own long-lived, disease-fighting T cells. Corner’s technology solves the “last mile” problem that has kept researchers from achieving the holy grails of medicine: therapeutic cancer and infectious disease vaccines that provide life-long immunity. Our antigen-agnostic platforms are revolutionizing care for an exceptionally wide range of cancers and infectious diseases.

Profile

  • Incorporated in
    Delaware
  • Established since
    2019
  • Main/Branch
    Branch

Address